China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Real-World Study of Irinotecan Hydrochloride Liposome Injection II in Patients with Pancreatic Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129421
Registration Time: 2026/08/04
Type: Observational study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336498
Published by HT Digital Content Services with permission from Health Daily Digest....